HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Krystyna Pawlak Selected Research

Chemokine CCL4

12/2004Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
1/2004Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
1/2004Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Krystyna Pawlak Research Topics

Disease

25Inflammation (Inflammations)
03/2024 - 08/2002
25Cardiovascular Diseases (Cardiovascular Disease)
03/2019 - 01/2002
24Chronic Renal Insufficiency
03/2024 - 10/2009
19Atherosclerosis
06/2012 - 07/2002
14Chronic Kidney Failure (Chronic Renal Failure)
01/2010 - 01/2005
9Neoplasms (Cancer)
12/2023 - 01/2008
7Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2008
7Carotid Artery Diseases
09/2012 - 05/2006
6Colonic Neoplasms (Colon Cancer)
12/2021 - 01/2017
6Anemia
01/2017 - 01/2002
6Renal Insufficiency (Renal Failure)
01/2017 - 08/2002
5Hepatitis
11/2007 - 08/2002
4Vascular Remodeling
03/2024 - 07/2005
4Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
08/2020 - 01/2007
4Hypertension (High Blood Pressure)
03/2019 - 04/2008
4Infections
04/2013 - 12/2004
3Uremia
01/2018 - 03/2013
3Bone Resorption
01/2017 - 01/2007
3Diabetes Mellitus
11/2012 - 08/2005
3Hypoxia (Hypoxemia)
01/2009 - 11/2005
2Breast Neoplasms (Breast Cancer)
12/2023 - 12/2020
2Acute Kidney Injury (Acute Renal Failure)
05/2022 - 01/2022
2Adenocarcinoma
04/2018 - 01/2018
2Thrombosis (Thrombus)
01/2018 - 06/2007
2Thrombophilia
09/2014 - 07/2009
2Glomerulonephritis
12/2011 - 12/2006
2Neoplasm Metastasis (Metastasis)
01/2009 - 01/2008
2Coronary Disease (Coronary Heart Disease)
04/2008 - 11/2003

Drug/Important Bio-Agent (IBA)

19C-Reactive ProteinIBA
03/2019 - 08/2002
17Superoxide Dismutase-1IBA
03/2019 - 01/2004
15KynurenineIBA
01/2022 - 01/2009
10oxidized low density lipoproteinIBA
03/2019 - 01/2004
9Matrix Metalloproteinases (MMPs)IBA
03/2024 - 09/2004
9ErythropoietinFDA Link
12/2020 - 01/2002
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012 - 11/2004
7Tryptophan (L-Tryptophan)FDA Link
01/2022 - 05/2009
7Proteins (Proteins, Gene)FDA Link
03/2019 - 08/2002
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2019 - 01/2004
7Thromboplastin (Tissue Factor)IBA
01/2018 - 01/2004
7CC ChemokinesIBA
09/2010 - 01/2004
7lipoprotein-associated coagulation inhibitor (TFPI)IBA
10/2009 - 01/2004
6CreatinineIBA
01/2017 - 08/2005
6AutoantibodiesIBA
09/2012 - 01/2004
6CytokinesIBA
01/2009 - 01/2004
6IronIBA
09/2007 - 08/2002
5MineralsIBA
10/2022 - 01/2016
5Hemostatics (Antihemorrhagics)IBA
01/2018 - 07/2002
5von Willebrand FactorIBA
01/2017 - 08/2002
5ThrombomodulinIBA
09/2009 - 08/2002
5PeroxidesIBA
06/2009 - 12/2004
5Prothrombin (Factor II)IBA
06/2007 - 01/2004
4Metalloproteases (Metalloproteinases)IBA
03/2024 - 09/2004
4IndicanIBA
01/2024 - 01/2017
4Parathyroid Hormone (Parathormone)IBA
12/2021 - 08/2002
4Serotonin (5 Hydroxytryptamine)IBA
08/2020 - 01/2016
4Interleukin-6 (Interleukin 6)IBA
03/2019 - 08/2002
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2010 - 01/2004
3LFM A13IBA
12/2020 - 01/2018
3LP533401IBA
08/2020 - 01/2018
3Uremic ToxinsIBA
03/2019 - 01/2017
3NeopterinIBA
03/2019 - 04/2013
3Phosphates (Orthophosphate)IBA
01/2019 - 06/2007
3anthranilic acid (anthranilate)IBA
01/2018 - 10/2009
3Urea (Carbamide)FDA LinkGeneric
01/2017 - 06/2007
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017 - 11/2004
3Biomarkers (Surrogate Marker)IBA
04/2013 - 08/2005
3AntioxidantsIBA
11/2012 - 12/2004
3Kynurenic Acid (Kynurenate)IBA
06/2012 - 06/2009
3Malondialdehyde (Propanedial)IBA
09/2009 - 01/2007
3Indicators and Reagents (Reagents)IBA
06/2009 - 11/2006
3EndoglinIBA
01/2009 - 01/2008
3HepcidinsIBA
07/2008 - 11/2005
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2008 - 01/2007
3ThrombinFDA Link
06/2007 - 03/2004
3EnzymesIBA
08/2005 - 08/2002
3Chemokine CCL4IBA
12/2004 - 01/2004
2Vitamin KFDA Link
10/2022 - 03/2021
2OsteocalcinIBA
10/2022 - 01/2007
21,2,4-triazineIBA
12/2021 - 06/2021
2Vitamin DFDA LinkGeneric
03/2021 - 01/2019
2Ferritins (Ferritin)IBA
03/2019 - 11/2006
2Plasminogen Activators (Plasminogen Activator)IBA
01/2018 - 01/2008
2LigandsIBA
01/2018 - 03/2017
2Plasminogen Activator Inhibitor 1IBA
01/2018 - 08/2002
2OsteoprotegerinIBA
01/2018 - 03/2017
2Alkaline PhosphataseIBA
01/2016 - 01/2007
2HomocysteineIBA
06/2012 - 01/2002
2Insulin-Like Growth Factor I (IGF-1)IBA
05/2011 - 01/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2011 - 01/2009
2Quinolinic AcidIBA
09/2009 - 06/2009
23-hydroxykynurenineIBA
09/2009 - 05/2009
2Fibrinogen (Factor I)FDA Link
07/2009 - 08/2002
2Transforming Growth Factor beta (TGF-beta)IBA
01/2009 - 01/2008

Therapy/Procedure

15Renal Dialysis (Hemodialysis)
04/2013 - 07/2002
10Therapeutics
12/2023 - 03/2002
6Conservative Treatment
03/2024 - 11/2006
6Continuous Ambulatory Peritoneal Dialysis (CAPD)
06/2012 - 06/2002
5Drug Therapy (Chemotherapy)
12/2023 - 01/2017
3Renal Replacement Therapy (Therapies, Renal Replacement)
11/2012 - 03/2006
3Peritoneal Dialysis
09/2012 - 01/2007